198 related articles for article (PubMed ID: 23721401)
1. The phenotype of dysferlin-deficient mice is not rescued by adeno-associated virus-mediated transfer of anoctamin 5.
Monjaret F; Suel-Petat L; Bourg-Alibert N; Vihola A; Marchand S; Roudaut C; Gicquel E; Udd B; Richard I; Charton K
Hum Gene Ther Clin Dev; 2013 Jun; 24(2):65-76. PubMed ID: 23721401
[TBL] [Abstract][Full Text] [Related]
2. Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer.
Lostal W; Bartoli M; Bourg N; Roudaut C; Bentaïb A; Miyake K; Guerchet N; Fougerousse F; McNeil P; Richard I
Hum Mol Genet; 2010 May; 19(10):1897-907. PubMed ID: 20154340
[TBL] [Abstract][Full Text] [Related]
3. Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.
Lostal W; Bartoli M; Roudaut C; Bourg N; Krahn M; Pryadkina M; Borel P; Suel L; Roche JA; Stockholm D; Bloch RJ; Levy N; Bashir R; Richard I
PLoS One; 2012; 7(5):e38036. PubMed ID: 22666441
[TBL] [Abstract][Full Text] [Related]
4. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.
Bolduc V; Marlow G; Boycott KM; Saleki K; Inoue H; Kroon J; Itakura M; Robitaille Y; Parent L; Baas F; Mizuta K; Kamata N; Richard I; Linssen WH; Mahjneh I; de Visser M; Bashir R; Brais B
Am J Hum Genet; 2010 Feb; 86(2):213-21. PubMed ID: 20096397
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Designed Nano-Dysferlin Significantly Improves Dysferlinopathy in BLA/J Mice.
Llanga T; Nagy N; Conatser L; Dial C; Sutton RB; Hirsch ML
Mol Ther; 2017 Sep; 25(9):2150-2162. PubMed ID: 28629822
[TBL] [Abstract][Full Text] [Related]
6. Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy.
Griffin DA; Johnson RW; Whitlock JM; Pozsgai ER; Heller KN; Grose WE; Arnold WD; Sahenk Z; Hartzell HC; Rodino-Klapac LR
Hum Mol Genet; 2016 May; 25(10):1900-1911. PubMed ID: 26911675
[TBL] [Abstract][Full Text] [Related]
7. Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer.
Grose WE; Clark KR; Griffin D; Malik V; Shontz KM; Montgomery CL; Lewis S; Brown RH; Janssen PM; Mendell JR; Rodino-Klapac LR
PLoS One; 2012; 7(6):e39233. PubMed ID: 22720081
[TBL] [Abstract][Full Text] [Related]
8. A naturally occurring human minidysferlin protein repairs sarcolemmal lesions in a mouse model of dysferlinopathy.
Krahn M; Wein N; Bartoli M; Lostal W; Courrier S; Bourg-Alibert N; Nguyen K; Vial C; Streichenberger N; Labelle V; DePetris D; Pécheux C; Leturcq F; Cau P; Richard I; Lévy N
Sci Transl Med; 2010 Sep; 2(50):50ra69. PubMed ID: 20861509
[TBL] [Abstract][Full Text] [Related]
9. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
[TBL] [Abstract][Full Text] [Related]
10. Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy.
Potter RA; Griffin DA; Sondergaard PC; Johnson RW; Pozsgai ER; Heller KN; Peterson EL; Lehtimäki KK; Windish HP; Mittal PJ; Albrecht DE; Mendell JR; Rodino-Klapac LR
Hum Gene Ther; 2018 Jul; 29(7):749-762. PubMed ID: 28707952
[TBL] [Abstract][Full Text] [Related]
11. A novel finding of anoctamin 5 expression in the rodent gastrointestinal tract.
Song HY; Tian YM; Zhang YM; Zhou L; Lian H; Zhu JX
Biochem Biophys Res Commun; 2014 Aug; 451(2):258-62. PubMed ID: 25094048
[TBL] [Abstract][Full Text] [Related]
12. Dual Adeno-Associated Virus 9 with Codon-Optimized DYSF Gene Promotes In Vivo Muscle Regeneration and May Decrease Inflammatory Response in Limb Girdle Muscular Dystrophy Type R2.
Yakovlev IA; Emelin AM; Slesarenko YS; Limaev IS; Vetrova IA; Belikova LD; Grafskaia EN; Bobrovsky PA; Pokrovsky MV; Kuzubova EV; Pokrovsky VM; Lebedev PA; Bardakov SN; Isaev AA; Deev RV
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686363
[TBL] [Abstract][Full Text] [Related]
13. Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
Ten Dam L; van der Kooi AJ; Rövekamp F; Linssen WH; de Visser M
Neuromuscul Disord; 2014 Dec; 24(12):1097-102. PubMed ID: 25176504
[TBL] [Abstract][Full Text] [Related]
14. A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.
Hicks D; Sarkozy A; Muelas N; Köehler K; Huebner A; Hudson G; Chinnery PF; Barresi R; Eagle M; Polvikoski T; Bailey G; Miller J; Radunovic A; Hughes PJ; Roberts R; Krause S; Walter MC; Laval SH; Straub V; Lochmüller H; Bushby K
Brain; 2011 Jan; 134(Pt 1):171-182. PubMed ID: 21186264
[TBL] [Abstract][Full Text] [Related]
15. Lipid accumulation in dysferlin-deficient muscles.
Grounds MD; Terrill JR; Radley-Crabb HG; Robertson T; Papadimitriou J; Spuler S; Shavlakadze T
Am J Pathol; 2014 Jun; 184(6):1668-76. PubMed ID: 24685690
[TBL] [Abstract][Full Text] [Related]
16. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD
Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057
[TBL] [Abstract][Full Text] [Related]
17. Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.
Gushchina LV; Bhattacharya S; McElhanon KE; Choi JH; Manring H; Beck EX; Alloush J; Weisleder N
Mol Ther; 2017 Oct; 25(10):2360-2371. PubMed ID: 28750735
[TBL] [Abstract][Full Text] [Related]
18. Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3' splice sites.
Philippi S; Lorain S; Beley C; Peccate C; Précigout G; Spuler S; Garcia L
Hum Mol Genet; 2015 Jul; 24(14):4049-60. PubMed ID: 25904108
[TBL] [Abstract][Full Text] [Related]
19. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
Rodino-Klapac LR; Lee JS; Mulligan RC; Clark KR; Mendell JR
Neurology; 2008 Jul; 71(4):240-7. PubMed ID: 18525034
[TBL] [Abstract][Full Text] [Related]
20. Defective membrane repair in dysferlin-deficient muscular dystrophy.
Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
